The PEARRL proposal has been evaluated positively and will therefore receive funding under the Marie Skłodowska-Curie Innovative Training Networks (H2020-MSCA-ITN-2015), under grant agreement no. 674909.
PEARRL (Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicine) brings together European Pharma industry, academia and regulatory agency partners in a multisectorial team to deliver a unique research and training programme for 15 Early Stage Researchers (ESR). It's aim is to train the the ESRs who will develop new bio-enabling formulations (“better drugs”), biorelevant and in silico methods to predict formulation performance in vivo (“streamlined development”) and serve as communication bridgers between research and regulatory science (“accelerated approval”), thus bringing Pharma and regulatory objectives to fruition.
RSS Feed
